Results 41 to 50 of about 659,528 (297)
Prevalence of influenza and pneumococcal vaccine uptake in Saudi type 2 diabetic individuals
Journal of Family Medicine and Primary Care, 2019 Introduction: Individuals with diabetes are at particularly at high risk for many of the negative health consequences associated with influenza and pneumococcal infections.
Y. A. Almusalam, M. Ghorab, S. Alanezi
semanticscholar +1 more source
Indian Journal of Medical Microbiology, 2018 Streptococcus pneumoniae continues to take a heavy toll on childhood mortality and morbidity across the developing world. An estimated 10.6 million invasive pneumococcal diseases (IPDs) occur every year, with nearly 1 million deaths in children under 5 years of age. Introduction of vaccines in the childhood immunisation programme in developed world has
Anand, Manoharan, Ranjith, Jayaraman
openaire +2 more sources
Clinical and experimental vaccine research, 2017 Purpose Previous studies have demonstrated the immunogenicity and safety of the co-administration of the trivalent inactivated influenza vaccine (IIV3) with the polysaccharide pneumococcal vaccine (PPV) or pneumococcal conjugate vaccine (PCV).
Y. Reddy +9 more
semanticscholar +1 more source
Expert Review of Vaccines, 2018 Introduction: Pneumococcal diseases (including septicemia, meningitis, pneumonia, and upper respiratory infections) constitute a major public health problem.
Tomas Mrkvan +4 more
doaj +1 more source
Severe polyserositis induced by the 13-valent pneumococcal conjugate vaccine: a case report
Journal of Medical Case Reports, 2017 Background The United States Advisory Committee on Immunization Practices recommends administration of the 13-valent pneumococcal conjugate vaccine in series with the 23-valent pneumococcal polysaccharide vaccine for prevention of pneumonia in the ...
Pierre Tawfik +2 more
doaj +1 more source
Barriers to pneumococcal conjugate 13 vaccination recommendations among physicians in Lagos
Babcock University Medical Journal, 2022 Objective: Vaccination rates among risk groups vary between different countries. There are gaps in the implementation of the acceptable recommended guidelines on adult pneumococcal immunization in Nigeria.
oluwafemi ojo
doaj +1 more source
Next-Generation Whole-Cell Pneumococcal Vaccine
Vaccines, 2019 Streptococcus pneumoniae remains a major public health hazard. Although Pneumococcal Conjugate Vaccines (PCVs) are available and have significantly reduced the rate of invasive pneumococcal diseases, there is still a need for new vaccines with unlimited ...
V. Morais, Esther Texeira, N. Suarez
semanticscholar +1 more source
Recommendations for pneumococcal immunization outside routine childhood immunization programs in Western Europe [PDF]
, 2014 The global burden of pneumococcal diseases is high, with young children and adults ≥50 years of age at highest risk of infection. Two types of vaccine are available for the prevention of pneumococcal diseases caused by specific Streptococcus pneumoniae ...
Castiglia, Paolo Giuseppino
core +1 more source
Human Vaccines & Immunotherapeutics, 2021 The recently published article by Shami et al. describes a cost-effectiveness analysis of sequential pneumococcal vaccination with 13-valent pneumococcal conjugate vaccine (PCV13) followed by 23-valent pneumococcal polysaccharide vaccine (PPSV23 ...
Ulrike K. Buchwald +2 more
doaj +1 more source
Nasopharyngeal S. pneumoniae carriage and density in Belgian infants after 9 years of pneumococcal conjugate vaccine programme [PDF]
, 2018 Background: In Belgium, the infant pneumococcal conjugate vaccine (PCV) programme changed from PCV7 (2007-2011) to PCV13 (2011-2015) and to PCV10 (2015-2016). A 3-year nasopharyngeal carriage study was initiated during the programme switch in 2016.
Blaizot, Stéphanie +10 more
core +2 more sources